The proposed bill establishes a new section, 465.191, in the Florida Statutes, specifically addressing compounding pharmacies. It defines key terms such as "chronically ill patient," "terminally ill patient," "compounding pharmacy," and "monographs." The bill authorizes chronically and terminally ill patients to work with their healthcare providers to determine individualized treatment plans using medications from compounding pharmacies. Additionally, it allows these pharmacies to access active pharmaceutical ingredients that lack a specific monograph, provided they are sourced from FDA-registered manufacturers and comply with quality specifications.

Furthermore, the bill outlines restrictions on the use of certain active pharmaceutical ingredients that have been withdrawn from the market for safety reasons or are listed under specific categories by the FDA. It explicitly states that the provisions do not permit any treatment intended to cause a patient's death. The act is set to take effect on July 1, 2025.